In this free webinar, see how DPYD testing can be implemented from guidelines to go-live through practical pharmacogenomics (PGx) reporting and workflow design. The featured speakers will share ...

Prostate cancer (PC) is a significant health concern, being the second leading cause of death among American men. The standard treatment for advanced PC often involves androgen deprivation therapy ...

KENILWORTH, N.J.--(BUSINESS WIRE)--With adverse drug events (ADEs) triggering an estimated 700,000 ED visits and 120,000 hospitalizations, RDx BioScience (RDx) points ...

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind ®, a leading mental health care company, is launching on August 10, 2019 Genomind Professional PGx Express™, a new, more focused report and set of ...

- Company Revamps Pharmacogenomics Go-To-Market Strategy, Targets Validated PGx Assay Towards Specific Use Cases - Capecitabine and 5-FU are used for the treatment of colorectal, esophageal, stomach, ...

STONY BROOK, NY / ACCESSWIRE / June 13, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that the New York ...

Susanne B. Haga ([email protected]) is an associate professor of medicine at the Duke University School of Medicine, in Durham, North Carolina. Ariel Kantor is an undergraduate research assistant at ...

This viewpoint is to provide and clarify details regarding the business article published on July 3, headlined “Dr. Julie Wharam hopes to bring pharmacogenomics to mainstream Grand Forks region.” Do ...

- Company Revamps Pharmacogenomics Go-To-Market Strategy, Targets Validated PGx Assay Towards Specific Use Cases - STONY BROOK, NY / ACCESS Newswire / April 1, 2025 / Applied DNA Sciences, Inc.